PL2463302T3 - Multiwalentne immunoglobuliny zmodyfikowane w regionie pętli strukturalnych - Google Patents
Multiwalentne immunoglobuliny zmodyfikowane w regionie pętli strukturalnychInfo
- Publication number
- PL2463302T3 PL2463302T3 PL11194316T PL11194316T PL2463302T3 PL 2463302 T3 PL2463302 T3 PL 2463302T3 PL 11194316 T PL11194316 T PL 11194316T PL 11194316 T PL11194316 T PL 11194316T PL 2463302 T3 PL2463302 T3 PL 2463302T3
- Authority
- PL
- Poland
- Prior art keywords
- loop region
- structural loop
- multivalent immunoglobulins
- modified
- immunoglobulins modified
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2887—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0114706A AT503889B1 (de) | 2006-07-05 | 2006-07-05 | Multivalente immunglobuline |
| EP07718518A EP2046831B1 (en) | 2006-07-05 | 2007-06-26 | Novel multivalent immunoglobulins |
| EP11194316.3A EP2463302B1 (en) | 2006-07-05 | 2007-06-26 | Multivalent immunoglobulins modified in the structural loop region |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2463302T3 true PL2463302T3 (pl) | 2015-08-31 |
Family
ID=38720179
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11194316T PL2463302T3 (pl) | 2006-07-05 | 2007-06-26 | Multiwalentne immunoglobuliny zmodyfikowane w regionie pętli strukturalnych |
| PL07718518T PL2046831T3 (pl) | 2006-07-05 | 2007-06-26 | Nowa wielowartościowa immunoglobulina |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07718518T PL2046831T3 (pl) | 2006-07-05 | 2007-06-26 | Nowa wielowartościowa immunoglobulina |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20100048877A1 (pl) |
| EP (2) | EP2463302B1 (pl) |
| JP (3) | JP5924751B2 (pl) |
| CN (3) | CN110041430A (pl) |
| AT (2) | AT503889B1 (pl) |
| DK (2) | DK2046831T3 (pl) |
| ES (2) | ES2380127T3 (pl) |
| HU (1) | HUE025035T2 (pl) |
| PL (2) | PL2463302T3 (pl) |
| PT (2) | PT2463302E (pl) |
| SI (2) | SI2046831T1 (pl) |
| WO (1) | WO2008003103A2 (pl) |
Families Citing this family (131)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3261856B2 (ja) | 1994-04-12 | 2002-03-04 | 東レ株式会社 | 溶融紡糸方法 |
| AU2006204459B2 (en) | 2005-01-05 | 2012-11-01 | F-Star Therapeutics Limited | Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| AT503889B1 (de) | 2006-07-05 | 2011-12-15 | Star Biotechnologische Forschungs Und Entwicklungsges M B H F | Multivalente immunglobuline |
| AT503902B1 (de) * | 2006-07-05 | 2008-06-15 | F Star Biotech Forsch & Entw | Verfahren zur manipulation von immunglobulinen |
| EP3409687A1 (en) | 2007-06-01 | 2018-12-05 | University of Maryland, Baltimore | Immunoglobulin constant region fc receptor binding agents |
| CN101802006B (zh) | 2007-06-26 | 2013-08-14 | F-星生物技术研究与开发有限公司 | 展示结合剂 |
| JP5592792B2 (ja) | 2007-09-26 | 2014-09-17 | ユセベ ファルマ ソシエテ アノニム | 二重特異性抗体の融合体 |
| BRPI0821906B1 (pt) | 2008-01-03 | 2022-06-07 | The Scripps Research Institute | Anticorpo isolado de comprimento total, seu uso, polinucleotideo, vetor, e célula hospedeira |
| US8557243B2 (en) | 2008-01-03 | 2013-10-15 | The Scripps Research Institute | EFGR antibodies comprising modular recognition domains |
| US8557242B2 (en) | 2008-01-03 | 2013-10-15 | The Scripps Research Institute | ERBB2 antibodies comprising modular recognition domains |
| US8454960B2 (en) | 2008-01-03 | 2013-06-04 | The Scripps Research Institute | Multispecific antibody targeting and multivalency through modular recognition domains |
| US8574577B2 (en) | 2008-01-03 | 2013-11-05 | The Scripps Research Institute | VEGF antibodies comprising modular recognition domains |
| WO2009099961A2 (en) * | 2008-01-31 | 2009-08-13 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Engineered antibody constant domain molecules |
| EP2113255A1 (en) | 2008-05-02 | 2009-11-04 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Cytotoxic immunoglobulin |
| EA201100527A1 (ru) | 2008-09-26 | 2011-10-31 | Юсб Фарма С.А. | Биологические продукты |
| US20120094874A1 (en) * | 2009-07-09 | 2012-04-19 | F-Star Biotechnologische Forschungs-Und Entwicklungsges. M.B.H | Stabilized immunoglobulin constant domains |
| WO2011028952A1 (en) | 2009-09-02 | 2011-03-10 | Xencor, Inc. | Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens |
| EP2407487A1 (en) | 2010-07-14 | 2012-01-18 | F-Star Biotechnologische Forschungs - und Entwicklungsges. M.B.H. | Multispecific modular antibody |
| US20120100166A1 (en) | 2010-07-15 | 2012-04-26 | Zyngenia, Inc. | Ang-2 Binding Complexes and Uses Thereof |
| CA2902942C (en) | 2010-07-28 | 2020-12-22 | David S. Block | Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin fc compositions |
| US8637641B2 (en) | 2010-07-29 | 2014-01-28 | Xencor, Inc. | Antibodies with modified isoelectric points |
| US20130273055A1 (en) | 2010-11-16 | 2013-10-17 | Eric Borges | Agents and methods for treating diseases that correlate with bcma expression |
| WO2012109553A2 (en) | 2011-02-11 | 2012-08-16 | Research Corporation Technologies | Ch2 domain template molecules derived from rational grafting of donor loops onto ch2 scaffolds |
| ES2704038T3 (es) | 2011-05-24 | 2019-03-13 | Zyngenia Inc | Complejos multiespecíficos multivalentes y monovalentes y sus usos |
| RU2641256C2 (ru) | 2011-06-30 | 2018-01-16 | Чугаи Сейяку Кабусики Кайся | Гетеродимеризованный полипептид |
| EP2546268A1 (en) | 2011-07-13 | 2013-01-16 | F-Star Biotechnologische Forschungs - und Entwicklungsges. M.B.H. | Internalising immunoglobulin |
| ES2659764T3 (es) * | 2011-08-23 | 2018-03-19 | Roche Glycart Ag | Moléculas biespecíficas de unión a antígeno activadoras de linfocitos T |
| US10851178B2 (en) | 2011-10-10 | 2020-12-01 | Xencor, Inc. | Heterodimeric human IgG1 polypeptides with isoelectric point modifications |
| US12466897B2 (en) | 2011-10-10 | 2025-11-11 | Xencor, Inc. | Heterodimeric human IgG1 polypeptides with isoelectric point modifications |
| CA2899433A1 (en) * | 2012-01-27 | 2013-08-01 | Gliknik Inc. | Fusion proteins comprising igg2 hinge domains |
| EP2862875B1 (en) * | 2012-06-14 | 2023-09-06 | Chugai Seiyaku Kabushiki Kaisha | ANTIGEN-BINDING MOLECULE CONTAINING MODIFIED Fc REGION |
| US9683044B2 (en) | 2012-08-20 | 2017-06-20 | Gliknik Inc. | Molecules with antigen binding and polyvalent FC gamma receptor binding activity |
| JP6433297B2 (ja) | 2012-12-27 | 2018-12-05 | 中外製薬株式会社 | ヘテロ二量化ポリペプチド |
| LT2943511T (lt) | 2013-01-14 | 2019-11-11 | Xencor Inc | Nauji heterodimeriniai baltymai |
| US10131710B2 (en) | 2013-01-14 | 2018-11-20 | Xencor, Inc. | Optimized antibody variable regions |
| US9701759B2 (en) | 2013-01-14 | 2017-07-11 | Xencor, Inc. | Heterodimeric proteins |
| US9605084B2 (en) | 2013-03-15 | 2017-03-28 | Xencor, Inc. | Heterodimeric proteins |
| US10487155B2 (en) | 2013-01-14 | 2019-11-26 | Xencor, Inc. | Heterodimeric proteins |
| US10968276B2 (en) | 2013-03-12 | 2021-04-06 | Xencor, Inc. | Optimized anti-CD3 variable regions |
| US11053316B2 (en) | 2013-01-14 | 2021-07-06 | Xencor, Inc. | Optimized antibody variable regions |
| EP2945969A1 (en) | 2013-01-15 | 2015-11-25 | Xencor, Inc. | Rapid clearance of antigen complexes using novel antibodies |
| US10519242B2 (en) | 2013-03-15 | 2019-12-31 | Xencor, Inc. | Targeting regulatory T cells with heterodimeric proteins |
| US10858417B2 (en) | 2013-03-15 | 2020-12-08 | Xencor, Inc. | Heterodimeric proteins |
| WO2014144600A2 (en) | 2013-03-15 | 2014-09-18 | Viktor Roschke | Multivalent and monovalent multispecific complexes and their uses |
| US10106624B2 (en) | 2013-03-15 | 2018-10-23 | Xencor, Inc. | Heterodimeric proteins |
| US10544187B2 (en) | 2013-03-15 | 2020-01-28 | Xencor, Inc. | Targeting regulatory T cells with heterodimeric proteins |
| US20160280787A1 (en) | 2013-11-11 | 2016-09-29 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule containing modified antibody variable region |
| AU2015237184B2 (en) | 2014-03-28 | 2020-11-26 | Xencor, Inc. | Bispecific antibodies that bind to CD38 and CD3 |
| NZ726514A (en) | 2014-05-29 | 2019-01-25 | Macrogenics Inc | Tri-specific binding molecules and methods of use thereof |
| TWI693232B (zh) | 2014-06-26 | 2020-05-11 | 美商宏觀基因股份有限公司 | 與pd-1和lag-3具有免疫反應性的共價結合的雙抗體和其使用方法 |
| AU2015303135B2 (en) | 2014-08-15 | 2021-05-20 | Merck Patent Gmbh | SIRP-alpha immunoglobulin fusion proteins |
| PE20170894A1 (es) | 2014-09-26 | 2017-07-12 | Macrogenics Inc | Diacuerpos monovalentes biepecificos que son capaces de unir cd19 y cd3 y usos de los mismos |
| JP7125248B2 (ja) | 2014-11-11 | 2022-08-24 | 中外製薬株式会社 | 改変された抗体可変領域を含む抗原結合分子のライブラリ |
| MA41019A (fr) | 2014-11-26 | 2021-05-05 | Xencor Inc | Anticorps hétérodimériques se liant aux antigènes cd3 et cd38 |
| US10259887B2 (en) | 2014-11-26 | 2019-04-16 | Xencor, Inc. | Heterodimeric antibodies that bind CD3 and tumor antigens |
| KR102689285B1 (ko) | 2014-11-26 | 2024-07-31 | 젠코어 인코포레이티드 | Ｃｄ3 및 종양 항원과 결합하는 이종이량체 항체 |
| JP6904902B2 (ja) * | 2014-12-05 | 2021-07-21 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | ドメイン交換抗体 |
| US10428155B2 (en) | 2014-12-22 | 2019-10-01 | Xencor, Inc. | Trispecific antibodies |
| TWI688572B (zh) | 2015-01-26 | 2020-03-21 | 美商宏觀基因股份有限公司 | 包含dr5-結合結構域的多價分子 |
| US10227411B2 (en) | 2015-03-05 | 2019-03-12 | Xencor, Inc. | Modulation of T cells with bispecific antibodies and FC fusions |
| TWI773646B (zh) | 2015-06-08 | 2022-08-11 | 美商宏觀基因股份有限公司 | 結合lag-3的分子和其使用方法 |
| SI3325011T1 (sl) | 2015-07-24 | 2021-02-26 | Gliknik Inc. | Fuzijski proteini humanih proteinskih fragmentov za tvorbo pravilnih multimeriziranih imunoglobulin FC sestavkov s povečanim vezanjem komplementa |
| MA58293B1 (fr) | 2015-07-30 | 2024-11-29 | Macrogenics, Inc. | Molécules de liaison pd-1 et leurs procédés d'utilisation |
| GEAP202114756A (en) | 2015-10-08 | 2021-07-26 | Macrogenics Inc | Combination therapy for the treatment of cancer |
| WO2017100372A1 (en) | 2015-12-07 | 2017-06-15 | Xencor, Inc. | Heterodimeric antibodies that bind cd3 and psma |
| CN108367069B (zh) | 2015-12-14 | 2022-08-23 | 宏观基因有限公司 | 对于pd-1和ctla-4具有免疫反应性的双特异性分子及其使用方法 |
| UY37127A (es) | 2016-02-17 | 2017-08-31 | Macrogenics Inc | Moléculas de unión a ror1, y métodos de uso de las mismas |
| PE20190353A1 (es) | 2016-04-15 | 2019-03-07 | Macrogenics Inc | Moleculas de union b7-h3 novedosas, conjugados anticuerpo-farmaco de los mismos y metodos de uso de los mismos |
| GB2550114A (en) | 2016-05-03 | 2017-11-15 | Kymab Ltd | Methods, regimens, combinations & antagonists |
| US11034775B2 (en) | 2016-06-07 | 2021-06-15 | Gliknik Inc. | Cysteine-optimized stradomers |
| KR102838691B1 (ko) | 2016-06-14 | 2025-07-25 | 젠코어 인코포레이티드 | 이중특이적 체크포인트 억제제 항체 |
| JP7085708B2 (ja) | 2016-06-20 | 2022-06-17 | エフ－スター セラピューティクス リミテッド | Ｌａｇ－３結合要素 |
| KR102379464B1 (ko) | 2016-06-20 | 2022-03-29 | 키맵 리미티드 | 항-pd-l1 항체 |
| CN116063545A (zh) | 2016-06-28 | 2023-05-05 | Xencor股份有限公司 | 结合生长抑素受体2的异源二聚抗体 |
| KR20230044038A (ko) | 2016-08-09 | 2023-03-31 | 키맵 리미티드 | 항-icos 항체 |
| US10793632B2 (en) | 2016-08-30 | 2020-10-06 | Xencor, Inc. | Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors |
| US10550185B2 (en) | 2016-10-14 | 2020-02-04 | Xencor, Inc. | Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and PD-1 antibody fragments |
| CA3043261A1 (en) | 2016-12-09 | 2018-06-14 | Gliknik Inc. | Manufacturing optimization of gl-2045, a multimerizing stradomer |
| CN110022898B (zh) | 2016-12-09 | 2023-07-04 | 格利克尼克股份有限公司 | 用多价Fc化合物治疗炎性疾病的方法 |
| AR110424A1 (es) | 2016-12-23 | 2019-03-27 | Macrogenics Inc | Moléculas de unión a adam9 y métodos de uso de las mismas |
| EP3574017A1 (en) | 2017-01-27 | 2019-12-04 | Kymab Limited | Anti-opg antibodies |
| EP4169937A1 (en) | 2017-02-17 | 2023-04-26 | Denali Therapeutics Inc. | Engineered transferrin receptor binding polypeptides |
| AU2018224094B2 (en) | 2017-02-24 | 2025-04-17 | Macrogenics, Inc. | Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof |
| EP3415527B1 (de) | 2017-06-14 | 2025-12-10 | Kymab Ltd. | Verwendung der extrazellulären domäne des transferrinrezeptor 2 zur diagnostik und behandlung von primär und sekundär sklerosierenden erkrankungen |
| GB201709970D0 (en) | 2017-06-22 | 2017-08-09 | Kymab Ltd | Bispecific antigen-binding molecules |
| JP2020529832A (ja) | 2017-06-30 | 2020-10-15 | ゼンコア インコーポレイテッド | ＩＬ−１５／ＩＬ−１５Ｒαおよび抗原結合ドメインを含む標的化ヘテロダイマーＦｃ融合タンパク質 |
| CA3071799C (en) | 2017-07-31 | 2022-12-13 | The University Of Tokyo | Super versatile method for presenting cyclic peptide motif on protein structure |
| PE20210347A1 (es) | 2017-10-02 | 2021-02-25 | Denali Therapeutics Inc | Proteinas de fusion que comprenden enzimas de terapia de reemplazo de enzimas |
| US11312770B2 (en) | 2017-11-08 | 2022-04-26 | Xencor, Inc. | Bispecific and monospecific antibodies using novel anti-PD-1 sequences |
| US10981992B2 (en) | 2017-11-08 | 2021-04-20 | Xencor, Inc. | Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors |
| TW201938194A (zh) | 2017-12-05 | 2019-10-01 | 日商中外製藥股份有限公司 | 包含結合cd3及cd137的改變的抗體可變區之抗原結合分子 |
| CA3085432A1 (en) | 2017-12-12 | 2019-06-20 | Macrogenics Inc. | Bispecific cd16-binding molecules and their use in the treatment of disease |
| WO2019122882A1 (en) | 2017-12-19 | 2019-06-27 | Kymab Limited | Bispecific antibody for icos and pd-l1 |
| IL275426B2 (en) | 2017-12-19 | 2025-03-01 | Xencor Inc | Engineered il-2 fc fusion proteins |
| GB201721338D0 (en) | 2017-12-19 | 2018-01-31 | Kymab Ltd | Anti-icos Antibodies |
| JP7337079B2 (ja) | 2018-02-15 | 2023-09-01 | マクロジェニクス，インコーポレーテッド | 変異型ｃｄ３結合ドメイン、及び疾患の治療のための併用療法におけるその使用 |
| EP3773911A2 (en) | 2018-04-04 | 2021-02-17 | Xencor, Inc. | Heterodimeric antibodies that bind fibroblast activation protein |
| US10654944B2 (en) | 2018-04-10 | 2020-05-19 | Y-Biologics Inc. | Cell engaging binding molecules |
| US11505595B2 (en) | 2018-04-18 | 2022-11-22 | Xencor, Inc. | TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and TIM-3 antigen binding domains |
| WO2019204665A1 (en) | 2018-04-18 | 2019-10-24 | Xencor, Inc. | Pd-1 targeted heterodimeric fusion proteins containing il-15/il-15ra fc-fusion proteins and pd-1 antigen binding domains and uses thereof |
| EP3806885A2 (en) | 2018-06-13 | 2021-04-21 | Kymab Limited | Antagonists and agonists of the transferrin receptor-2 for use in the treatment of diseases of the bone |
| GB201811415D0 (en) | 2018-07-12 | 2018-08-29 | F Star Beta Ltd | Anti-Mesothelin Anti bodies |
| EP3820898B1 (en) | 2018-07-12 | 2025-09-03 | invoX Pharma Limited | Antibody molecules that bind cd137 and ox40 |
| GB201811410D0 (en) * | 2018-07-12 | 2018-08-29 | F Star Beta Ltd | OX40 Binding molecules |
| GB201811404D0 (en) | 2018-07-12 | 2018-08-29 | F Star Beta Ltd | Anti-CD137 Antibodies |
| GB201811450D0 (en) | 2018-07-12 | 2018-08-29 | F Star Delta Ltd | Mesothelin and CD137 binding molecules |
| GB201811408D0 (en) | 2018-07-12 | 2018-08-29 | F Star Beta Ltd | CD137 Binding Molecules |
| MX2021000398A (es) | 2018-07-12 | 2021-05-27 | F Star Therapeutics Ltd | Moleculas de anticuerpo que se unen a pd-l1 y cd137. |
| GB201811403D0 (en) | 2018-07-12 | 2018-08-29 | F Star Beta Ltd | Antibody molecules |
| GB201815629D0 (en) | 2018-09-25 | 2018-11-07 | Kymab Ltd | Antagonists |
| JP7612571B2 (ja) | 2018-10-03 | 2025-01-14 | ゼンコア インコーポレイテッド | Ｉｌ－１２ヘテロ二量体ｆｃ－融合タンパク質 |
| GB201820687D0 (en) | 2018-12-19 | 2019-01-30 | Kymab Ltd | Antagonists |
| CN114885609B (zh) | 2018-12-24 | 2026-02-17 | 赛诺菲 | 基于假Fab的多特异性结合蛋白 |
| BR112021016955A2 (pt) | 2019-03-01 | 2021-11-23 | Xencor Inc | Composição, composição de ácido nucleico, composição de vetor de expressão, vetor de expressão, célula hospedeira, métodos de produção de um domínio de ligação de membro de família 3 de pirofosfatase/fosfodiesterase de ectonucleotídeo e de tratamento de um câncer, anticorpo anti-enpp3, e, anticorpo heterodimérico |
| GB201905552D0 (en) | 2019-04-18 | 2019-06-05 | Kymab Ltd | Antagonists |
| IL296803A (en) | 2020-03-31 | 2022-11-01 | Chugai Pharmaceutical Co Ltd | Multispecific antigen binding molecules targeting dll3 and their uses |
| GB202007099D0 (en) | 2020-05-14 | 2020-07-01 | Kymab Ltd | Tumour biomarkers for immunotherapy |
| WO2021231976A1 (en) | 2020-05-14 | 2021-11-18 | Xencor, Inc. | Heterodimeric antibodies that bind prostate specific membrane antigen (psma) and cd3 |
| US20240279353A1 (en) | 2020-07-06 | 2024-08-22 | Kiromic BioPharma, Inc. | Mesothelin isoform binding molecules and chimeric pd1 receptor molecules, cells containing the same and uses thereof |
| KR20230166150A (ko) | 2020-08-19 | 2023-12-06 | 젠코어 인코포레이티드 | 항-cd28 조성물 |
| GB202017058D0 (en) | 2020-10-27 | 2020-12-09 | Kymab Ltd | Antibodies and uses thereof |
| CA3202233A1 (en) | 2020-11-18 | 2022-05-27 | Kiromic BioPharma, Inc. | Gamma-delta t cell manufacturing processes and chimeric pd1 receptor molecules |
| GB202101125D0 (en) | 2021-01-27 | 2021-03-10 | Kymab Ltd | Antibodies and uses thereof |
| JP2024511319A (ja) | 2021-03-09 | 2024-03-13 | ゼンコア インコーポレイテッド | Ｃｄ３及びｃｌｄｎ６に結合するヘテロ二量体抗体 |
| JP2024509274A (ja) | 2021-03-10 | 2024-02-29 | ゼンコア インコーポレイテッド | Ｃｄ３及びｇｐｃ３に結合するヘテロ二量体抗体 |
| CA3217220A1 (en) * | 2021-04-19 | 2022-10-27 | Janssen Biotech, Inc. | Molecules with engineered antibody constant region variants |
| GB202107372D0 (en) | 2021-05-24 | 2021-07-07 | Petmedix Ltd | Animal models and therapeutics molecules |
| GB202209247D0 (en) | 2022-06-23 | 2022-08-10 | Petmedix Ltd | Animal models and therapeutic molecules |
| GB202217978D0 (en) | 2022-11-30 | 2023-01-11 | Petmedix Ltd | Rodents expressing a common light chain |
| KR20250124877A (ko) | 2022-12-19 | 2025-08-20 | 아스트라제네카 아베 | 자가면역 질환의 치료 |
| IL322179A (en) | 2023-01-30 | 2025-09-01 | Kymab Ltd | Antibodies |
Family Cites Families (104)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0174366B1 (en) | 1984-03-01 | 1994-10-26 | The Board Of Trustees Of The Leland Stanford Junior University | T-cell receptor-specific for antigen polypeptides and related polynucleotides |
| DE3590766T (pl) | 1985-03-30 | 1987-04-23 | ||
| US6492107B1 (en) | 1986-11-20 | 2002-12-10 | Stuart Kauffman | Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5750373A (en) | 1990-12-03 | 1998-05-12 | Genentech, Inc. | Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| JPH05502586A (ja) * | 1989-12-27 | 1993-05-13 | セントカー・インコーポレーテツド | Ｃｄ４受容体に対するキメラ免疫グロブリン |
| JP3283041B2 (ja) * | 1990-07-13 | 2002-05-20 | 学校法人藤田学園 | 人工抗体 |
| WO1992018619A1 (en) | 1991-04-10 | 1992-10-29 | The Scripps Research Institute | Heterodimeric receptor libraries using phagemids |
| US5270170A (en) | 1991-10-16 | 1993-12-14 | Affymax Technologies N.V. | Peptide library and screening method |
| US5395750A (en) | 1992-02-28 | 1995-03-07 | Hoffmann-La Roche Inc. | Methods for producing proteins which bind to predetermined antigens |
| CA2135408A1 (en) | 1992-05-08 | 1993-11-25 | Peter C. Keck | Chimeric multivalent protein analogues and methods of use thereof |
| US5844094A (en) | 1992-09-25 | 1998-12-01 | Commonwealth Scientific And Industrial Research Organization | Target binding polypeptide |
| US5536814A (en) * | 1993-09-27 | 1996-07-16 | La Jolla Cancer Research Foundation | Integrin-binding peptides |
| ATE204300T1 (de) * | 1994-05-13 | 2001-09-15 | Biovation Ltd | Zielzellen-bindende chimäre peptide |
| GB9501079D0 (en) | 1995-01-19 | 1995-03-08 | Bioinvent Int Ab | Activation of T-cells |
| AUPO591797A0 (en) | 1997-03-27 | 1997-04-24 | Commonwealth Scientific And Industrial Research Organisation | High avidity polyvalent and polyspecific reagents |
| US5783186A (en) | 1995-12-05 | 1998-07-21 | Amgen Inc. | Antibody-induced apoptosis |
| US6358709B1 (en) | 1995-12-07 | 2002-03-19 | Diversa Corporation | End selection in directed evolution |
| US6352842B1 (en) * | 1995-12-07 | 2002-03-05 | Diversa Corporation | Exonucease-mediated gene assembly in directed evolution |
| US6361974B1 (en) * | 1995-12-07 | 2002-03-26 | Diversa Corporation | Exonuclease-mediated nucleic acid reassembly in directed evolution |
| JP4046354B2 (ja) | 1996-03-18 | 2008-02-13 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 増大した半減期を有する免疫グロブリン様ドメイン |
| US6696251B1 (en) | 1996-05-31 | 2004-02-24 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| WO1998039482A1 (en) | 1997-03-07 | 1998-09-11 | Sunol Molecular Corporation | Fusion proteins comprising bacteriophage coat protein and a single-chain t cell receptor |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| CA2293632C (en) | 1997-06-12 | 2011-11-29 | Research Corporation Technologies, Inc. | Artificial antibody polypeptides |
| GB9722131D0 (en) | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
| EP1071700B1 (en) | 1998-04-20 | 2010-02-17 | GlycArt Biotechnology AG | Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| US6180343B1 (en) | 1998-10-08 | 2001-01-30 | Rigel Pharmaceuticals, Inc. | Green fluorescent protein fusions with random peptides |
| US6818418B1 (en) | 1998-12-10 | 2004-11-16 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| US6376246B1 (en) * | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| ATE465459T1 (de) | 1999-01-19 | 2010-05-15 | Maxygen Inc | Durch oligonukleotide-vermittelte nukleinsäuren- rekombination |
| WO2000052155A2 (en) | 1999-03-05 | 2000-09-08 | Maxygen, Inc. | Recombination of insertion modified nucleic acids |
| US6472147B1 (en) | 1999-05-25 | 2002-10-29 | The Scripps Research Institute | Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries |
| AU779612C (en) | 1999-07-02 | 2005-12-15 | Genentech Inc. | Peptide compounds that bind HER2 |
| AU5076301A (en) | 1999-12-06 | 2001-07-09 | Board Of Trustees Of The University Of Illinois, The | High affinity tcr proteins and methods |
| EP1118661A1 (en) | 2000-01-13 | 2001-07-25 | Het Nederlands Kanker Instituut | T cell receptor libraries |
| JP2003274960A (ja) | 2000-02-03 | 2003-09-30 | Japan Science & Technology Corp | 可溶性ｔ細胞受容体タンパク質およびその作成方法 |
| EP1259601A2 (en) | 2000-02-22 | 2002-11-27 | Ahuva Nissim | Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof |
| AU2001243670A1 (en) | 2000-03-20 | 2001-10-03 | Maxygen, Inc. | Method for generating recombinant dna molecules in complex mixtures |
| JP2003533187A (ja) * | 2000-05-03 | 2003-11-11 | アムジエン・インコーポレーテツド | 治療薬としてのＦｃドメインを含む修飾ペプチド |
| AU2001261628A1 (en) | 2000-05-16 | 2001-11-26 | Euroceltique S.A. | Cd28 synthebody for the modulation of immune responses |
| JP2004511430A (ja) | 2000-05-24 | 2004-04-15 | イムクローン システムズ インコーポレイティド | 二重特異性免疫グロブリン様抗原結合蛋白および製造方法 |
| US6406863B1 (en) | 2000-06-23 | 2002-06-18 | Genetastix Corporation | High throughput generation and screening of fully human antibody repertoire in yeast |
| WO2002006469A2 (en) | 2000-07-18 | 2002-01-24 | Enchira Biotechnology Corporation | Methods of ligation mediated chimeragenesis utilizing populations of scaffold and donor nucleic acids |
| CA2417185A1 (en) * | 2000-07-25 | 2002-01-31 | Shui-On Leung | Multivalent target binding protein |
| JP2002058479A (ja) | 2000-08-14 | 2002-02-26 | Canon Inc | 構造認識アミノ酸配列の取得方法 |
| WO2002032925A2 (en) * | 2000-10-16 | 2002-04-25 | Phylos, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| US20040082508A1 (en) | 2000-11-08 | 2004-04-29 | Henry Yue | Secreted proteins |
| GB0029407D0 (en) | 2000-12-01 | 2001-01-17 | Affitech As | Product |
| AU2002248184C1 (en) | 2000-12-12 | 2018-01-04 | Board Of Regents, The University Of Texas System | Molecules with extended half-lives, compositions and uses thereof |
| JP2005505236A (ja) | 2000-12-19 | 2005-02-24 | アルトー バイオサイエンス コーポレイション | ヒト化免疫系を含むトランスジェニック動物 |
| IL141539A0 (en) | 2001-02-20 | 2002-03-10 | Yeda Res & Dev | Dna molecules and cells transfected therewith |
| US20030157561A1 (en) | 2001-11-19 | 2003-08-21 | Kolkman Joost A. | Combinatorial libraries of monomer domains |
| ATE472609T1 (de) | 2001-04-26 | 2010-07-15 | Amgen Mountain View Inc | Kombinatorische bibliotheken von monomerdomänen |
| EP1281757A1 (en) | 2001-07-31 | 2003-02-05 | Direvo Biotech AG | Method for the production of nucleic acids consisting of stochastically combined parts of source nucleic acids |
| CA2457652C (en) | 2001-08-31 | 2012-08-07 | Avidex Limited | Soluble t cell receptor |
| WO2003029456A1 (en) | 2001-10-01 | 2003-04-10 | Dyax Corp. | Multi-chain eukaryotic display vectors and uses thereof |
| WO2003034995A2 (en) | 2001-10-22 | 2003-05-01 | The Scripps Research Institute | Integrin targeting compounds |
| US20040043424A1 (en) | 2001-11-15 | 2004-03-04 | Baughn Mariah R | Immunoglobulin superfamily proteins |
| US20050069549A1 (en) * | 2002-01-14 | 2005-03-31 | William Herman | Targeted ligands |
| US20040063924A1 (en) | 2002-01-28 | 2004-04-01 | Y Tom Tang | Secreted proteins |
| US20030157091A1 (en) | 2002-02-14 | 2003-08-21 | Dyax Corporation | Multi-functional proteins |
| US20040018508A1 (en) | 2002-02-19 | 2004-01-29 | Syntherica Corporation | Surrogate antibodies and methods of preparation and use thereof |
| US7317091B2 (en) | 2002-03-01 | 2008-01-08 | Xencor, Inc. | Optimized Fc variants |
| US20040132101A1 (en) | 2002-09-27 | 2004-07-08 | Xencor | Optimized Fc variants and methods for their generation |
| AU2003213687A1 (en) | 2002-03-04 | 2003-09-22 | Imclone Systems Incorporated | Human antibodies specific to kdr and uses thereof |
| US20040097711A1 (en) | 2002-03-12 | 2004-05-20 | Henry Yue | Immunoglobulin superfamily proteins |
| EP1394251A1 (en) | 2002-08-23 | 2004-03-03 | Direvo Biotech AG | Method for the selective randomization of polynucleotides |
| EP1549748B1 (en) | 2002-10-09 | 2014-10-01 | Immunocore Ltd. | Single chain recombinant t cell receptors |
| JP2006520584A (ja) | 2002-11-08 | 2006-09-14 | アブリンクス エン．ヴェー． | 安定化単一ドメイン抗体 |
| ES2327229T3 (es) | 2002-11-09 | 2009-10-27 | Immunocore Ltd. | Presentacion del receptor de linfocitos t. |
| WO2004050705A2 (en) | 2002-12-03 | 2004-06-17 | Avidex Ltd. | Complexes of receptors |
| GB0304068D0 (en) | 2003-02-22 | 2003-03-26 | Avidex Ltd | Substances |
| EP1644416A4 (en) * | 2003-06-30 | 2007-08-29 | Centocor Inc | ANTI-TARGET AND GENETICALLY MODIFIED IMMUNOGLOBULIN-DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES |
| WO2005021595A1 (en) | 2003-08-28 | 2005-03-10 | Euro-Celtique S.A. | Methods of antibody engineering using antibody display rules |
| JP4906094B2 (ja) * | 2004-01-16 | 2012-03-28 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | レセプターを活性化し得る融合ポリペプチド |
| EP1737890A2 (en) | 2004-03-24 | 2007-01-03 | Xencor, Inc. | Immunoglobulin variants outside the fc region |
| US7785903B2 (en) * | 2004-04-09 | 2010-08-31 | Genentech, Inc. | Variable domain library and uses |
| WO2005114215A2 (en) | 2004-05-19 | 2005-12-01 | Avidex Ltd | Method of improving t cell receptors |
| DK1765860T3 (da) | 2004-05-19 | 2009-03-09 | Immunocore Ltd | Ny-ESO-T.cellereceptor med höj affinitet |
| GB0411773D0 (en) | 2004-05-26 | 2004-06-30 | Avidex Ltd | Method for the identification of polypeptides which bind to a given peptide mhc complex or cd 1-antigen complex |
| ZA200701234B (en) | 2004-07-22 | 2008-12-31 | Genentech Inc | HER2 antibody composition |
| AU2005289685B2 (en) | 2004-09-24 | 2009-07-16 | Amgen Inc. | Modified Fc molecules |
| WO2006037960A2 (en) | 2004-10-01 | 2006-04-13 | Avidex Ltd. | T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents |
| US7632497B2 (en) | 2004-11-10 | 2009-12-15 | Macrogenics, Inc. | Engineering Fc Antibody regions to confer effector function |
| EP1812574A2 (en) | 2004-11-18 | 2007-08-01 | Avidex Limited | Soluble bifunctional proteins |
| GB0425732D0 (en) | 2004-11-23 | 2004-12-22 | Avidex Ltd | Gamma-delta t cell receptors |
| AU2006204459B2 (en) | 2005-01-05 | 2012-11-01 | F-Star Therapeutics Limited | Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| GB0503546D0 (en) | 2005-02-21 | 2005-03-30 | Hellenic Pasteur Inst | Antibody |
| US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
| US20080227958A1 (en) * | 2006-04-14 | 2008-09-18 | Trubion Pharmaceuticals Inc. | Binding proteins comprising immunoglobulin hinge and fc regions having altered fc effector functions |
| AT503902B1 (de) | 2006-07-05 | 2008-06-15 | F Star Biotech Forsch & Entw | Verfahren zur manipulation von immunglobulinen |
| AT503889B1 (de) | 2006-07-05 | 2011-12-15 | Star Biotechnologische Forschungs Und Entwicklungsges M B H F | Multivalente immunglobuline |
| EP1975178A1 (en) | 2007-03-30 | 2008-10-01 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Transcytotic modular antibody |
| CN101802006B (zh) | 2007-06-26 | 2013-08-14 | F-星生物技术研究与开发有限公司 | 展示结合剂 |
| WO2009099961A2 (en) | 2008-01-31 | 2009-08-13 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Engineered antibody constant domain molecules |
| EP2113255A1 (en) | 2008-05-02 | 2009-11-04 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Cytotoxic immunoglobulin |
| US20120094874A1 (en) | 2009-07-09 | 2012-04-19 | F-Star Biotechnologische Forschungs-Und Entwicklungsges. M.B.H | Stabilized immunoglobulin constant domains |
| US20120010388A1 (en) | 2010-04-16 | 2012-01-12 | Gottfried Himmler | LeY SPECIFIC BIOTHERAPEUTIC |
| EP2407487A1 (en) | 2010-07-14 | 2012-01-18 | F-Star Biotechnologische Forschungs - und Entwicklungsges. M.B.H. | Multispecific modular antibody |
| US20140087957A1 (en) | 2012-09-25 | 2014-03-27 | Marko Vuskovic | Methods, assays and kits for cancer diagnosis and screening utilizing glycan-binding and glycan epitopes |
| GB201317622D0 (en) | 2013-10-04 | 2013-11-20 | Star Biotechnology Ltd F | Cancer biomarkers and uses thereof |
-
2006
- 2006-07-05 AT AT0114706A patent/AT503889B1/de not_active IP Right Cessation
-
2007
- 2007-06-26 ES ES07718518T patent/ES2380127T3/es active Active
- 2007-06-26 ES ES11194316.3T patent/ES2539593T3/es active Active
- 2007-06-26 HU HUE11194316A patent/HUE025035T2/en unknown
- 2007-06-26 CN CN201811561773.1A patent/CN110041430A/zh active Pending
- 2007-06-26 PT PT111943163T patent/PT2463302E/pt unknown
- 2007-06-26 DK DK07718518.9T patent/DK2046831T3/da active
- 2007-06-26 JP JP2009516813A patent/JP5924751B2/ja active Active
- 2007-06-26 PL PL11194316T patent/PL2463302T3/pl unknown
- 2007-06-26 AT AT07718518T patent/ATE540056T1/de active
- 2007-06-26 PT PT07718518T patent/PT2046831E/pt unknown
- 2007-06-26 SI SI200730848T patent/SI2046831T1/sl unknown
- 2007-06-26 CN CN201811561771.2A patent/CN110078828A/zh active Pending
- 2007-06-26 PL PL07718518T patent/PL2046831T3/pl unknown
- 2007-06-26 US US12/307,578 patent/US20100048877A1/en not_active Abandoned
- 2007-06-26 EP EP11194316.3A patent/EP2463302B1/en active Active
- 2007-06-26 DK DK11194316.3T patent/DK2463302T3/en active
- 2007-06-26 WO PCT/AT2007/000313 patent/WO2008003103A2/en not_active Ceased
- 2007-06-26 EP EP07718518A patent/EP2046831B1/en active Active
- 2007-06-26 CN CNA200780032991XA patent/CN101522712A/zh active Pending
- 2007-06-26 SI SI200731662T patent/SI2463302T1/sl unknown
-
2013
- 2013-07-11 JP JP2013145770A patent/JP6215603B2/ja active Active
-
2017
- 2017-06-20 JP JP2017120279A patent/JP6681855B2/ja active Active
- 2017-08-15 US US15/677,667 patent/US11827720B2/en active Active
-
2023
- 2023-11-28 US US18/521,492 patent/US20240150495A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN101522712A (zh) | 2009-09-02 |
| SI2463302T1 (sl) | 2015-08-31 |
| JP2017163998A (ja) | 2017-09-21 |
| US20180051095A1 (en) | 2018-02-22 |
| WO2008003103A2 (en) | 2008-01-10 |
| JP6681855B2 (ja) | 2020-04-15 |
| EP2046831A2 (en) | 2009-04-15 |
| US20100048877A1 (en) | 2010-02-25 |
| US11827720B2 (en) | 2023-11-28 |
| ES2380127T3 (es) | 2012-05-08 |
| CN110078828A (zh) | 2019-08-02 |
| ATE540056T1 (de) | 2012-01-15 |
| EP2046831B1 (en) | 2012-01-04 |
| AT503889A1 (de) | 2008-01-15 |
| EP2463302A1 (en) | 2012-06-13 |
| ES2539593T3 (es) | 2015-07-02 |
| WO2008003103A3 (en) | 2008-04-17 |
| DK2046831T3 (da) | 2012-05-29 |
| JP2013240338A (ja) | 2013-12-05 |
| HUE025035T2 (en) | 2016-01-28 |
| PT2463302E (pt) | 2015-07-21 |
| JP5924751B2 (ja) | 2016-05-25 |
| PL2046831T3 (pl) | 2012-06-29 |
| EP2463302B1 (en) | 2015-04-01 |
| PT2046831E (pt) | 2012-04-24 |
| JP6215603B2 (ja) | 2017-10-18 |
| JP2009540837A (ja) | 2009-11-26 |
| CN110041430A (zh) | 2019-07-23 |
| SI2046831T1 (sl) | 2012-03-30 |
| DK2463302T3 (en) | 2015-06-15 |
| US20240150495A1 (en) | 2024-05-09 |
| AT503889B1 (de) | 2011-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2463302T3 (pl) | Multiwalentne immunoglobuliny zmodyfikowane w regionie pętli strukturalnych | |
| SG10201610247QA (en) | Antibody variants having modifications in the constant region | |
| IL208045A0 (en) | Antibody against the csf-1r | |
| SI2099826T1 (sl) | Anti-beta-amiloidno protitelo in njegova uporaba | |
| IL205355A0 (en) | Anti- hepcidin antibodies and uses thereof | |
| IL194266A0 (en) | Anti-igf-ir antibodies and uses thereof | |
| HRP20180873T1 (hr) | Humanizirana anti-cxcr5 protutijela, njihovi derivati i njihova upotreba | |
| IL182704A0 (en) | Klipped kippahs: the kippahs with built-in clips | |
| SI1973950T1 (sl) | Anti-EphB4 protitelesa in postopki njihove uporabe | |
| EP2025971A4 (en) | CANVAS FOR SYNCHRONIZED BELTS AND SYNCHRONIZED STRAPS | |
| TWI348277B (en) | Phase-locked loop and control method utilizing the same | |
| ZA201103941B (en) | Anti-ferroportin 1 monoclonal antibodies and uses thereof | |
| IL175806A0 (en) | Winged structural joint and articles employing the joint | |
| PL2027320T3 (pl) | Siatka i sposób wytwarzania siatki | |
| GB0620679D0 (en) | The Re:tie | |
| GB0602141D0 (en) | The turboramjet | |
| GB0618347D0 (en) | The wonder strap | |
| IL183169A0 (en) | Ornament maunfactured using the capsulation method | |
| GB0701613D0 (en) | The smooth swing | |
| GB0621198D0 (en) | The drop back | |
| GB0612173D0 (en) | Angle bead super fixer | |
| GB0700030D0 (en) | The tie shirt | |
| GB0804882D0 (en) | The boomerang pillow | |
| GB0702806D0 (en) | The children pansaver | |
| GB0725167D0 (en) | Easy tie loop |